Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance

Inflammatory Bowel Diseases

Volumn 18, Issue 5, 2012, Pages 832-837

  Goldstone, Robert ^a   Itzkowitz, Steven ^a   Harpaz, Noam ^a   Ullman, Thomas ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy location; Dysplasia; Surveillance colonoscopy; Ulcerative colitis

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; DYSPLASIA; FEMALE; FISHER EXACT TEST; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLON; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84859791701     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21809     Document Type: Article

References (14)

1. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology. 2004;126:1634-1648. (Pubitemid 38649879)
2. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314-321. (Pubitemid 40439686)
3. Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology. 1992;103:431-438.
4. Farraye FA, Odze RD, Eaden J, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:746-774, 774 e741-744; quiz e712-743.
5. Choi PM. Predominance of rectosigmoid neoplasia in ulcerative colitis and its implication on cancer surveillance. Gastroenterology. 1993;104:666-667. (Pubitemid 23033448)
6. Lindberg B, Persson B, Veress B, et al. Twenty years' colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scand J Gastroenterol. 1996;31:1195-1204. (Pubitemid 26403095)
7. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030-1038.
8. Ullman T, Croog V, Harpaz N, et al. Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine. Clin Gastroenterol Hepatol. 2008;6:1225-1230; quiz 1177.
9. Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099-1105; quiz 1340-1091.
10. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968.
11. Awais D, Siegel CA, Higgins PD. Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity. Gut. 2009;58:1498-1503.
12. Connell WR, Talbot IC, Harpaz N, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut. 1994;35:1419-1423. (Pubitemid 24310904)
13. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459. (Pubitemid 38182302)
14. Melville DM, Jass JR, Morson BC, et al. Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol. 1989;20:1008-1014. (Pubitemid 19267907)